These results demonstrate that reprogramming of TAMs to M1 phenotype by deletion of PRDX1 effectively suppresses CRC growth and improves the efficacy of ICIs by enhancing CD8+ T‐cell‐mediated anti‐tumor immunity. This evidence concerns the gene PRDX1 and colorectal carcinoma.